An exciting revolution in health care and medical technology looms large on the horizon. Yet the agents of change will be microscopically small, future products of a new discipline known as nanotechnology. Nanotechnology is the engineering of molecularly precise structures e typically 0.1 mm or smaller e and, ultimately, molecular machines. Nanomedicine 1e4 is the application of nanotechnology to medicine. It is the preservation and improvement of human health, using molecular tools and molecular knowledge of the human body. Present-day nanomedicine exploits carefully structured nanoparticles such as dendrimers, 5 carbon fullerenes (buckyballs) 6 and nanoshells 7 to target specific tissues and organs. These nanoparticles may serve as diagnostic and therapeutic antiviral, antitumor or anticancer agents. But as this technology matures in the years ahead, complex nanodevices and even nanorobots will be fabricated, first of biological materials but later using more durable materials such as diamond to achieve the most powerful results.
Early vision
Can it be that someday nanorobots will be able to travel through the body searching out and clearing up diseases, such as an arterial atheromatous plaque? 8 The first and most famous scientist to voice this possibility was the late Nobel physicist Richard P. Feynman. In his remarkably prescient 1959 talk ''There's Plenty of Room at the Bottom,'' Feynman proposed employing machine tools to make smaller machine tools, these are to be used in turn to make still smaller machine tools, and so on all the way down to the atomic level, noting that this is ''a development which I think cannot be avoided.'' 9 Feynman was clearly aware of the potential medical applications of this new technology. He offered the first known proposal for a nanorobotic surgical procedure to cure heart disease: ''A friend of mine (Albert R. Hibbs) suggests a very interesting possibility for relatively small machines. He says that, although it is a very wild idea, it would be interesting in surgery if you could swallow the surgeon. You put the mechanical surgeon inside the blood vessel and it goes into the heart and looks around. (Of course the information has to be fed out.) It finds out which valve is the faulty one and takes a little knife and slices it out. .[Imagine] that we can manufacture an object that maneuvers at that level!. Other small machines might be permanently incorporated in the body to assist some inadequately functioning organ.'' 9 
Medical microrobotics
There are ongoing attempts to build microrobots for in vivo medical use. In 2002, Ishiyama et al. at Tohoku University developed tiny magnetically driven spinning screws intended to swim along veins and carry drugs to infected tissues or even to burrow into tumors and kill them with heat. 10 In 2003, the ''MR-Sub'' project of Martel's group at the NanoRobotics Laboratory of Ecole Polytechnique in Montreal tested using variable MRI magnetic fields to generate forces on an untethered microrobot containing ferromagnetic particles, developing sufficient propulsive power to direct the small device through the human body.
11 Brad Nelson's team at the Swiss Federal Institute of Technology in Zurich continued this approach. In 2005, they reported the fabrication of a microscopic robot small enough (w200 mm) to be injected into the body through a syringe. They hope that this device or its descendants might someday be used to deliver drugs or perform minimally invasive eye surgery. 12 Nelson's simple microrobot has successfully maneuvered through a watery maze using external energy from magnetic fields, with different frequencies that are able to vibrate different mechanical parts on the device to maintain selective control of different functions. Gordon's group at the University of Manitoba has also proposed magnetically controlled ''cytobots'' and ''karyobots'' for performing wireless intracellular and intranuclear surgery. 13 
Manufacturing medical nanorobots
The greatest power of nanomedicine will emerge, perhaps in the 2020s, when we can design and construct complete artificial nanorobots using rigid diamondoid nanometer-scale parts like molecular gears ( Fig. 1) and bearings.
14 These nanorobots will possess a full panoply of autonomous subsystems including onboard sensors, motors, manipulators, power supplies, and molecular computers. But getting all these nanoscale components to spontaneously self-assemble in the right sequence will prove increasingly difficult as machine structures become more complex. Making complex nanorobotic systems requires manufacturing techniques that can build a molecular structure by what is called positional assembly. This will involve picking and placing molecular parts one by one, moving them along controlled trajectories much like the robot arms that manufacture cars on automobile assembly lines. The procedure is then repeated over and over with all the different parts until the final product, such as a medical nanorobot, is fully assembled.
The positional assembly of diamondoid structures, some almost atom by atom, using molecular feedstock has been examined theoretically 14,15 via computational models of diamond mechanosynthesis (DMS). DMS is the controlled addition of carbon atoms to the growth surface of a diamond crystal lattice in a vacuum-manufacturing environment. Covalent chemical bonds are formed one by one as the result of positionally constrained mechanical forces applied at the tip of a scanning probe microscope apparatus, following a programmed sequence. Mechanosynthesis using silicon atoms was first achieved experimentally in 2003. 16 Carbon atoms should not be far behind. 17 To be practical, molecular manufacturing must also be able to assemble very large numbers of medical nanorobots very quickly. Approaches under consideration include using replicative manufacturing systems or massively parallel fabrication, employing large arrays of scanning probe tips all building similar diamondoid product structures in unison. 18 For example, simple mechanical ciliary arrays consisting of 10,000 independent microactuators on a 1-cm 2 chip have been made at the Cornell National Nanofabrication Laboratory for microscale parts transport applications, and similarly at IBM for mechanical data storage applications. 19 Active probe arrays of 10,000 independently actuated microscope tips have been developed by Mirkin's group at Northwestern University for dip-pen nanolithography 20 using DNA-based ''ink''. Almost any desired 2D shape can be drawn using 10 tips in concert. Another microcantilever array manufactured by Protiveris Corp. has millions of interdigitated cantilevers on a single chip. Martel's group has investigated using fleets of independently mobile wireless instrumented microrobot manipulators called NanoWalkers to collectively form a nanofactory system that might be used for positional manufacturing operations. 21 Zyvex Corp. (www.zyvex.com) of Richardson, TX has a $25 million, five-year, National Institute of Standards and Technology (NIST) contract to develop prototype microscale assemblers using microelectromechanical systems. This research may eventually lead to prototype nanoscale assemblers using nanoelectromechanical systems. 
Respirocytes and microbivores
The abil ity to build compl ex diamondo id medi cal nanoro bots to mole cular pre cision, and the n to build the m cheaply enough in sufficient ly large numbers to be useful thera peuticall y, will revo lutioniz e the pra ctice of medi cine and surger y. 1 The first theoreti cal de sign study of a compl ete medical nanorobo t ever publish ed in a peer-rev iewed journal (in 1998) described a hy pothetica l artifici al mecha nical re d blood cell or ''re spirocyt e'' made of 18 b illion preci sely arr anged structur al atom s. 22 The resp irocyte is a bloodborne spheri cal 1-m m diamo ndoid 1000-atm osphere pressure vess el with revers ible molec ule-selec tive surface pumps powered by end ogenous serum glucos e. This nanoro bot would deliver 236 times more oxygen to bod y tissues per unit volume tha n nat ural red cells and would ma nage carbo nic acidity, cont rolled by gas conc entratio n sensors and an onboard nanoco mputer. A 5-cc thera peutic dose of 50% resp irocyte saline suspen sion conta ining 5 trillio n nano robots could exactly repl ace the gas car rying capaci ty of the patient 's entir e 5.4 l of blood.
Nanor obotic artifi cial phagocyt es called ''microbivores '' (Fig. 2) could patro l the bloodstrea m, seekin g out and diges ting unwant ed pat hogens includ ing bacte ria, virus es, or fungi. 23 Micro bivores would achie ve compl ete clearan ce of even the most severe septicem ic infections in hours or less. This is far bett er than the weeks or months need ed for ant ibioti c-assisted natu ral phagocyt ic defen ses. The nanorobo ts do not increas e the risk of seps is or septic shock because the pathoge ns are completel y digested into harmle ss sugars, amino aci ds and the like, which are the only effluent s from the nanorobot.
Surgical nanorobotics
Surgica l nano robots could be intr oduce d into the body through the vascul ar system or at the ends of cathe ters into vario us vessels and other cavi ties in the human body. A surgica l nanorobo t, programm ed or guided by a human surgeon, could act as a sem i-auton omous on-site surgeon inside the human bod y. Such a device could perform variou s fun ctions such as searchi ng for patho logy and then diagnosi ng and cor recting lesions b y nanoma nipulati on, coor dinated by an onboa rd comput er while ma intaining c ontact w ith the supervi sing surgeo n via code d ultra sound signals. The earli est for ms of cellular nanos urgery are already being explored today. For example, a rapidly vibrating (100 Hz) micropipette with a <1-mm tip diameter has been used to completely cut dendrites from single neurons without damaging cell viability. 24 Axotomy of roundworm neurons was performed by femtosecond laser surgery, after which the axons functionally regenerated. 25 A femtolaser acts like a pair of ''nano-scissors'' by vaporizing tissue locally while leaving adjacent tissue unharmed. Femtolaser surgery has performed the follo wing: (1) localized nanosu rgical abla tion of focal adhesions adjoining live mammalian epithelial cells, 26 (2) microtubule dissection inside yeast cells, 27 (3) noninvasive intratissue nanodissection of plant cell walls and selective destruction of intracellular single plastids or selected parts of them, 28 and even (4) the nanosurgery of individual chromosomes (selectively knocking out genomic nanometer-sized regions within the nucleus of living Chinese hamster ovary cells 29 ). These procedures do not kill the cells upon which the nanosurgery was performed. Atomic force microscopes have also been used for bacterium cell wall dissection in situ in aqueous solution, with 26 nm thick twisted strands revealed inside the cell wall after mechanically peeling back large patches of the outer cell wall. 30 Future nanorobots equipped with operating instruments and mobility will be able to perform precise and refined intracellular surgeries which are beyond the capabilities of direct manipulation by the human hand. We envision biocompatible 31 surgical nanorobots that can find and eliminate isolated cancerous cells, remove microvascular obstructions and recondition vascular endothelial cells, perform ''noninvasive'' tissue and organ transplants, conduct molecular repairs on traumatized extracellular and intracellular structures, and even exchange new whole chromosomes for old ones inside individual living human cells. 
